CNS Pharmaceuticals, Inc. (CNSP) › Operating IncomeCNS Pharmaceuticals, Inc. (CNSP) — Operating IncomeAnnual figures by period end, from SEC filings.2018-12-31: -$881.8K2019-12-31: -$3.83M2020-12-31: -$9.45M2021-12-31: -$14.49M2022-12-31: -$15.27M2023-12-31: -$18.87M2024-12-31: -$14.90M2025-12-31: -$15.99M-$15.99M2018-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31-$15.99M—2026-03-31From 2025-01-012024-12-31-$14.90M—2026-03-31From 2024-01-012023-12-31-$18.87M—2025-03-31From 2023-01-012022-12-31-$15.27M—2024-04-01From 2022-01-012021-12-31-$14.49M—2023-03-31From 2021-01-012020-12-31-$9.45M—2022-03-03From 2020-01-012019-12-31-$3.83M—2021-02-12From 2019-01-012018-12-31-$881.8K—2020-03-12From 2018-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)